JPWO2023074888A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023074888A5 JPWO2023074888A5 JP2023556697A JP2023556697A JPWO2023074888A5 JP WO2023074888 A5 JPWO2023074888 A5 JP WO2023074888A5 JP 2023556697 A JP2023556697 A JP 2023556697A JP 2023556697 A JP2023556697 A JP 2023556697A JP WO2023074888 A5 JPWO2023074888 A5 JP WO2023074888A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- monoclonal antibody
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021178982 | 2021-11-01 | ||
| JP2021178982 | 2021-11-01 | ||
| JP2022005967 | 2022-01-18 | ||
| JP2022005967 | 2022-01-18 | ||
| PCT/JP2022/040580 WO2023074888A1 (ja) | 2021-11-01 | 2022-10-31 | 新規なＮａｖ１．７モノクローナル抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023074888A1 JPWO2023074888A1 (https=) | 2023-05-04 |
| JPWO2023074888A5 true JPWO2023074888A5 (https=) | 2024-03-01 |
| JP7457880B2 JP7457880B2 (ja) | 2024-03-28 |
Family
ID=86159498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556697A Active JP7457880B2 (ja) | 2021-11-01 | 2022-10-31 | 新規なＮａｖ１．７モノクローナル抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250163145A1 (https=) |
| EP (1) | EP4428239A4 (https=) |
| JP (1) | JP7457880B2 (https=) |
| KR (1) | KR102753603B1 (https=) |
| AU (1) | AU2022377536B2 (https=) |
| CA (1) | CA3236404A1 (https=) |
| CO (1) | CO2024003915A2 (https=) |
| IL (1) | IL311683B2 (https=) |
| MX (1) | MX2024004393A (https=) |
| MY (1) | MY206945A (https=) |
| TW (1) | TWI867354B (https=) |
| WO (1) | WO2023074888A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024225446A1 (ja) * | 2023-04-28 | 2024-10-31 | 塩野義製薬株式会社 | 新規なＮａｖ１．７モノクローナル抗体を含む医薬組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214973B1 (en) | 1993-11-19 | 2001-04-10 | Chugai Seiyaku Kabushiki Kaisha | Reshaped human antibody to human medulloblastoma cells |
| DE69535243T2 (de) | 1994-07-13 | 2007-05-10 | Chugai Seiyaku K.K. | Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper |
| EP0962467A4 (en) | 1996-09-26 | 2002-10-30 | Chugai Pharmaceutical Co Ltd | Antibody against human parathormone related peptides |
| CN102781963B (zh) | 2009-10-27 | 2018-02-16 | Ucb医药有限公司 | 功能修饰性NAv1.7抗体 |
| GB0922434D0 (en) | 2009-12-22 | 2010-02-03 | Ucb Pharma Sa | antibodies and fragments thereof |
| MX2015010749A (es) | 2013-03-14 | 2015-11-30 | Regeneron Pharma | Anticuerpos humanos para nav1.7. |
| JP2016529909A (ja) * | 2013-09-05 | 2016-09-29 | デューク ユニバーシティ | Ｎａｖ１．７抗体及び前記抗体を使用する方法 |
| GB2517953A (en) | 2013-09-05 | 2015-03-11 | Argen X Bv | Antibodies to complex targets |
| JPWO2019230856A1 (ja) * | 2018-05-31 | 2021-06-24 | 塩野義製薬株式会社 | Ｎａｖ１．７モノクローナル抗体 |
| US20240002497A1 (en) | 2020-11-19 | 2024-01-04 | Merck Sharp & Dohme Llc | Nav1.7 binders |
| WO2024225446A1 (ja) * | 2023-04-28 | 2024-10-31 | 塩野義製薬株式会社 | 新規なＮａｖ１．７モノクローナル抗体を含む医薬組成物 |
-
2022
- 2022-10-31 JP JP2023556697A patent/JP7457880B2/ja active Active
- 2022-10-31 MX MX2024004393A patent/MX2024004393A/es unknown
- 2022-10-31 KR KR1020247018286A patent/KR102753603B1/ko active Active
- 2022-10-31 AU AU2022377536A patent/AU2022377536B2/en active Active
- 2022-10-31 IL IL311683A patent/IL311683B2/en unknown
- 2022-10-31 EP EP22887213.1A patent/EP4428239A4/en active Pending
- 2022-10-31 WO PCT/JP2022/040580 patent/WO2023074888A1/ja not_active Ceased
- 2022-10-31 MY MYPI2024001218A patent/MY206945A/en unknown
- 2022-10-31 US US18/705,139 patent/US20250163145A1/en active Pending
- 2022-10-31 CA CA3236404A patent/CA3236404A1/en active Pending
- 2022-10-31 TW TW111141378A patent/TWI867354B/zh active
-
2024
- 2024-03-27 CO CONC2024/0003915A patent/CO2024003915A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025160458A5 (https=) | ||
| JP2019054802A5 (https=) | ||
| JP2024038003A5 (https=) | ||
| EA201190132A1 (ru) | Гуманизированные антитела, связывающиеся с cd19, и их применение | |
| JP2017114866A5 (https=) | ||
| RU2018146050A (ru) | Биспецифические связывающие белки, которые связывают иммуномодулирующий белок и опухолевый антиген | |
| RU2017134495A (ru) | Антитела к альфа-рецептору собачьего интерлейкина-4 | |
| JP2018516853A5 (https=) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| NZ623706A (en) | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof | |
| JP2023093753A5 (https=) | ||
| JP2017505125A5 (https=) | ||
| JP2021500916A5 (https=) | ||
| JP2021130676A5 (https=) | ||
| JP2021502984A5 (https=) | ||
| RU2016107814A (ru) | Новое антитело к tslp-рецептору человека | |
| JP2023525695A5 (https=) | ||
| JP2023520969A5 (https=) | ||
| JP2010509937A5 (https=) | ||
| JP2009509538A5 (https=) | ||
| RU2014127287A (ru) | Антитела, используемые для пассивной вакцинации против гриппа | |
| FI4031569T3 (fi) | Kantasolutekijän vasta-aineet ja niiden käyttömenetelmät | |
| EA202192907A1 (ru) | Моноклональное антитело, которое специфически связывается с gitr | |
| JP2022500455A5 (https=) | ||
| JP2023182689A5 (https=) |